These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32299841)

  • 1. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients.
    van der Zwan M; Hesselink DA; Brusse E; van Doorn PA; van den Hoogen MWF; de Weerd AE; Jacobs BC
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32299841
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barre/CIDP-like neuropathy in two parkinsonian patients following intestinal levodopa/carbidopa treatment.
    Galazky I; Schoof J; Stallforth S; Kupsch A; Heinze HJ; Kluge C
    Parkinsonism Relat Disord; 2014 Jan; 20(1):125-7. PubMed ID: 24044946
    [No Abstract]   [Full Text] [Related]  

  • 3. Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies.
    Fargeot G; Dupel-Pottier C; Stephant M; Lazarovici J; Thomas L; Mouthon-Reignier C; Riad B; Carde P; Berzero G; Tafani C; Nicolas W; Viala K; Maisonobe T; Lenglet T; Wang A; Magy L; Bihan K; Gaspar N; Adams D; Echaniz-Laguna A; Cauquil C; Psimaras D
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):786-788. PubMed ID: 32327451
    [No Abstract]   [Full Text] [Related]  

  • 4. Does Induction Type Influence Outcomes in Kidney Transplant Recipients at Different Phases of Hepatitis B Infection?
    Sureshkumar KK; Chopra B
    Exp Clin Transplant; 2019 Aug; 17(4):457-460. PubMed ID: 30066624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment with thymoglobulin as the cause of acute demyelinating polyneuropathy in a renal transplant patient].
    Romero A; Sola E; López V; Gutiérrez C; Cabello M; González-Molina M; Burgos D; Hernández D
    Nefrologia; 2009; 29(4):369-70. PubMed ID: 19668317
    [No Abstract]   [Full Text] [Related]  

  • 6. No indication of increased infection rates using low-dose alemtuzumab instead of anti-thymocyte globulin as graft-versus-host disease prophylaxis before allogeneic stem cell transplantation.
    Neumann T; Schneidewind L; Thiele T; Pink D; Schulze M; Schmidt C; Krüger W
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual patients who experienced both Guillain-Barré syndrome and CIDP.
    Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
    J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical Clinical Presentations of Pediatric Acute Immune-Mediated Polyneuropathy.
    Yosha-Orpaz N; Aharoni S; Rabie M; Nevo Y
    J Child Neurol; 2019 Apr; 34(5):268-276. PubMed ID: 30674221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia.
    Kaya B; Davies CE; Oakervee HE; Silver NC; Gawler J; Cavenagh JD
    J Clin Pathol; 2005 Sep; 58(9):994-5. PubMed ID: 16126887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients.
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32769202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic inflammatory polyradiculoneuropathy].
    Nicolas G
    Rev Med Interne; 2008 Jun; 29 Spec No 2():1-8. PubMed ID: 18927988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction associated with initial alemtuzumab infusion cycle in relapsing-remitting multiple sclerosis.
    Romba MC; Newsome SD; McArthur JC
    Mult Scler Relat Disord; 2019 Sep; 34():100-102. PubMed ID: 31252364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation.
    Pritchard J; Mukherjee R; Hughes RA
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):348-9. PubMed ID: 12185184
    [No Abstract]   [Full Text] [Related]  

  • 17. Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin.
    Park SH; Choi SM; Lee DG; Choi JH; Yoo JH; Kim SH; Kim HJ; Cho SG; Eom KS; Lee JW; Min WS; Shin WS; Kim CC
    Transpl Infect Dis; 2009 Oct; 11(5):413-23. PubMed ID: 19708893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of POEMS mimicking a "Guillain-Barré like" syndrome.
    Abbas A; Cook M; Hiew FL; Lewthwaite A; Shirley C; Rajabally YA
    J Neurol Sci; 2016 Oct; 369():268-270. PubMed ID: 27653904
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Pham HP; Schwartz J
    Presse Med; 2019 Nov; 48(11 Pt 2):338-346. PubMed ID: 31679897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori may play an important role in both axonal type Guillain-Barré syndrome and acute inflammatory demyelinating polyradiculoneuropathy.
    Kountouras J; Zavos C; Deretzi G; Gavalas E; Polyzos S; Vardaka E; Kountouras C; Giartza-Taxidou E; Koutlas E; Tsiptsios I
    Clin Neurol Neurosurg; 2011 Jul; 113(6):520. PubMed ID: 21316838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.